Clinical trial
Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in…
NCT00017641 · Northwestern Memorial Hospital, Other · Unknown status
Key facts
| NCT number | NCT00017641 |
|---|---|
| Title | Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus |
| Lead sponsor | Northwestern Memorial Hospital, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug, Procedure |
| Interventions | anti-thymocyte globulin, cyclophosphamide, filgrastim, CD34+ Peripheral Blood Stem Cell Reinfusion |
| Enrollment | 10 |
| Start date | Apr 1, 2001 |
| First posted | Jun 6, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: